Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mikael Dolsten
Biotech
Mikael Dolsten to leave Pfizer, sparking search for successor
After 15 years, including a career-defining pandemic period, the chief scientific officer will leave Pfizer once the drugmaker finds his successor.
Nick Paul Taylor
Jul 9, 2024 8:50am
Mikael Dolsten preps Pfizer's entry into obesity's 2nd wave
Feb 13, 2024 9:50am
Pfizer shuffles R&D leadership to prepare for Seagen merger
Jul 27, 2023 9:05am
Pfizer to boost R&D spend in ’23 despite rare disease rethink
Jan 31, 2023 2:13pm
Pfizer's R&D president Dolsten on COVID vaccine R&D
Jan 22, 2021 8:35am
